$85.74 -1.25 (-1.44%)
11/27/2009 1:00 PM

Express Scripts, Inc. (ESRX)

CAPS Rating: 3 out of 5

Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers.

Results 1 - 20 of 70 1 2 3 4 Next »

Recs

0
Member Avatar SierraBlue (< 20) Submitted: 11/17/2009 6:53:39 PM : Outperform Start Price: $85.70 ESRX Score: +1.57

Mad Money - Cramer Pick

Recs

0
Member Avatar mrbill6 (< 20) Submitted: 11/15/2009 10:02:28 AM : Outperform Start Price: $85.19 ESRX Score: +1.38

msn: 8, navallier:B

Recs

0
Member Avatar potluckfool (56.38) Submitted: 9/17/2009 10:37:05 AM : Outperform Start Price: $78.51 ESRX Score: +6.73

Financial performance has continued to improve. Net income out paced sales yr. over yr. Drug benefit mgr. cos. should be less affected by new gov. intervention than drug cos. Purchase of Wellpoint should give ESRX a major advantage in the growing drug discount market.

Recs

0
Member Avatar Volunteer508 (< 20) Submitted: 9/12/2009 10:38:57 AM : Outperform Start Price: $78.13 ESRX Score: +4.05

This is a healthcare cost containment stock and should not be affected by any Government remodeling of the healthcare field and may even benefit from it. I say it will outperform the market.

Recs

0
Member Avatar timspicksstocks1 (35.28) Submitted: 8/28/2009 11:12:55 PM : Outperform Start Price: $72.00 ESRX Score: +11.50

cramer says

Recs

0
Member Avatar sk8terman (79.10) Submitted: 8/24/2009 10:29:38 AM : Outperform Start Price: $70.95 ESRX Score: +14.67

Will benefit from gov. cost cutting plan in a huge way.

Recs

0
Member Avatar BLAYNE100 (87.72) Submitted: 7/31/2009 11:18:20 PM : Outperform Start Price: $69.74 ESRX Score: +12.72

Quality Healthcare likely to be next growth sector in Q3/Q4 of 2009

Recs

0
Member Avatar normanroy (< 20) Submitted: 7/24/2009 10:23:52 PM : Outperform Start Price: $70.39 ESRX Score: +9.53

Good chart setup, good rating from IBD, Good rating from MSN, good rating from VectorVest

Recs

0
Member Avatar braned3 (54.35) Submitted: 7/2/2009 10:39:48 PM : Outperform Start Price: $65.97 ESRX Score: +5.94

Have had a big run, but a little more to go. Nice space in drug market.

Recs

0
Member Avatar Turtlebale (30.55) Submitted: 6/23/2009 6:38:47 PM : Outperform Start Price: $65.64 ESRX Score: +8.52

buying the wellpoint captive PBM will be worth more than the street thinks

Recs

0
Member Avatar drgdog (89.88) Submitted: 12/9/2008 11:00:02 PM : Outperform Start Price: $58.97 ESRX Score: +20.96

Insurance companies are mandating generic drugs.

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:03 PM : Outperform Start Price: $52.15 ESRX Score: +22.09

ibd

Recs

0
Member Avatar tarotkid (38.44) Submitted: 10/31/2008 4:23:51 PM : Underperform Start Price: $62.61 ESRX Score: -20.91

unjustified valuation

Recs

0
Member Avatar RXDOC73 (99.18) Submitted: 10/28/2008 3:30:13 PM : Outperform Start Price: $62.86 ESRX Score: +47.83

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Recs

0
Member Avatar sampsrl (< 20) Submitted: 10/16/2008 10:59:45 AM : Outperform Start Price: $56.69 ESRX Score: +27.74

This company has it's hands in all aspects of Pharmaceuticals except for actually making them. They deliver drugs. That's it. They handle all the crap in the middle between the Phamaceutical companies and you including home delievery. With an aging Baby Boom market who will require more medications, these guys are in the right position at the right time. At 44 even I am taking meds! Their numbers are excemplary. Superior marks for Operating Margin Growth and ROE. Above average on Cash flow, Earnings Momentum, Revisions, and Growth. Sales Growth ... not the best, but It'll do for me. This is a great play in Health Care sector...

Recs

0
Member Avatar christianphil (84.00) Submitted: 10/6/2008 3:04:02 PM : Outperform Start Price: $65.86 ESRX Score: +20.94

I managed to get with the program here for my CAPS paper-trading health, while trying to stay out of this very sick market for real.

Recs

0
Member Avatar jjherncaps (41.92) Submitted: 9/25/2008 8:15:01 PM : Outperform Start Price: $72.54 ESRX Score: +23.60

Provider of pharmacy benefit management services. Costumers include third-party administrators, health insurers and employers. Offers home delivery, benefit design consultation, disease management services, and various specialty services like patient care, marketing, and customized logistics solutions

Recs

0
Member Avatar Actionman2go (< 20) Submitted: 9/9/2008 1:18:44 PM : Outperform Start Price: $72.63 ESRX Score: +28.04

Medical to try and stabilize my bleeding portfolio

Recs

0
Member Avatar richardrogers4 (64.96) Submitted: 9/7/2008 4:25:46 AM : Outperform Start Price: $72.84 ESRX Score: +29.44

LN Pick

Recs

0
Member Avatar nysegal (26.14) Submitted: 8/5/2008 2:24:22 AM : Outperform Start Price: $71.15 ESRX Score: +30.81

Issue currently trading at less than 20 x > earnings of 3.61 estim for 09; company has a underlying growth rate of 31% although earnings in 09 will be 18% over 08. Co recently beat EPS estimates and raised forcast earnings.

Results 1 - 20 of 70 1 2 3 4 Next »

Featured Broker Partners